DC_YM21
DC_YM21 is an inhibitor of menin-MLL interaction with potent and selective proliferation blocking activity. DC_YM21 can induce cell cycle arrest and differentiation of leukemia cells carrying MLL translocation. DC_YM21 shows potential application value in inhibiting MLL leukemia[1].
Product Specifications
CAS Number
2001072-35-9
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dc-ym21.html
Smiles
NCC(C1CCCC1)(CCN2CC=C(CC2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4
Molecular Formula
C26H33ClN2
Molecular Weight
409.01
References & Citations
[1]Identification of novel small-molecule inhibitors targeting menin-MLL interaction, repurposing the antidiarrheal loperamide
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1028992-01 0.02 mg (E-Coli)
Recombinant Shewanella baltica RNA pyrophosphohydrolase (rppH)
Sign In for Pricing
View Details MBS1028992-02 0.1 mg (E-Coli)
Recombinant Shewanella baltica RNA pyrophosphohydrolase (rppH)
Sign In for Pricing
View Details MBS1028992-03 0.02 mg (Yeast)
Recombinant Shewanella baltica RNA pyrophosphohydrolase (rppH)
Sign In for Pricing
View Details